IBDEI059 ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6849,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,6849,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,6849,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,6850,0)
 ;;=V19.0^^59^431^6
 ;;^UTILITY(U,$J,358.3,6850,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6850,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,6850,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,6850,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,6851,0)
 ;;=V16.3^^59^431^7
 ;;^UTILITY(U,$J,358.3,6851,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6851,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,6851,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,6851,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,6852,0)
 ;;=V16.41^^59^431^10
 ;;^UTILITY(U,$J,358.3,6852,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6852,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,6852,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,6852,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,6853,0)
 ;;=V16.42^^59^431^11
 ;;^UTILITY(U,$J,358.3,6853,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6853,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,6853,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,6853,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,6854,0)
 ;;=V16.43^^59^431^12
 ;;^UTILITY(U,$J,358.3,6854,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6854,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,6854,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,6854,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,6855,0)
 ;;=V19.5^^59^431^13
 ;;^UTILITY(U,$J,358.3,6855,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6855,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,6855,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,6855,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,6856,0)
 ;;=V19.2^^59^431^14
 ;;^UTILITY(U,$J,358.3,6856,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6856,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,6856,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,6856,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,6857,0)
 ;;=V17.3^^59^431^16
 ;;^UTILITY(U,$J,358.3,6857,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6857,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,6857,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,6857,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,6858,0)
 ;;=V16.6^^59^431^17
 ;;^UTILITY(U,$J,358.3,6858,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6858,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,6858,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,6858,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,6859,0)
 ;;=V18.61^^59^431^19
 ;;^UTILITY(U,$J,358.3,6859,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6859,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,6859,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,6859,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,6860,0)
 ;;=V17.0^^59^431^20
 ;;^UTILITY(U,$J,358.3,6860,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6860,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,6860,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,6860,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,6861,0)
 ;;=V19.4^^59^431^21
 ;;^UTILITY(U,$J,358.3,6861,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6861,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,6861,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,6861,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,6862,0)
 ;;=V17.1^^59^431^22
 ;;^UTILITY(U,$J,358.3,6862,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6862,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,6862,1,5,0)
 ;;=5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,6862,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,6863,0)
 ;;=V16.8^^59^431^18
 ;;^UTILITY(U,$J,358.3,6863,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6863,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,6863,1,5,0)
 ;;=5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,6863,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,6864,0)
 ;;=V11.1^^59^431^41
 ;;^UTILITY(U,$J,358.3,6864,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6864,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,6864,1,5,0)
 ;;=5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,6864,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,6865,0)
 ;;=V15.89^^59^431^49
 ;;^UTILITY(U,$J,358.3,6865,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6865,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,6865,1,5,0)
 ;;=5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,6865,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,6866,0)
 ;;=V11.3^^59^431^42
 ;;^UTILITY(U,$J,358.3,6866,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6866,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,6866,1,5,0)
 ;;=5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,6866,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,6867,0)
 ;;=V15.07^^59^431^43
 ;;^UTILITY(U,$J,358.3,6867,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6867,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,6867,1,5,0)
 ;;=5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,6867,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,6868,0)
 ;;=V13.4^^59^431^44
 ;;^UTILITY(U,$J,358.3,6868,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6868,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,6868,1,5,0)
 ;;=5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,6868,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,6869,0)
 ;;=V12.72^^59^431^45
 ;;^UTILITY(U,$J,358.3,6869,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6869,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,6869,1,5,0)
 ;;=5^Personal h/o Colon Polyps
 ;;^UTILITY(U,$J,358.3,6869,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,6870,0)
 ;;=V12.59^^59^431^46
 ;;^UTILITY(U,$J,358.3,6870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6870,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,6870,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,6870,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,6871,0)
 ;;=V45.81^^59^431^47
 ;;^UTILITY(U,$J,358.3,6871,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6871,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,6871,1,5,0)
 ;;=5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,6871,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,6872,0)
 ;;=V15.84^^59^431^48
 ;;^UTILITY(U,$J,358.3,6872,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6872,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,6872,1,5,0)
 ;;=5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,6872,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,6873,0)
 ;;=V15.85^^59^431^53
 ;;^UTILITY(U,$J,358.3,6873,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6873,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,6873,1,5,0)
 ;;=5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,6873,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,6874,0)
 ;;=V10.72^^59^431^51
 ;;^UTILITY(U,$J,358.3,6874,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6874,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,6874,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,6874,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,6875,0)
 ;;=V15.3^^59^431^52
 ;;^UTILITY(U,$J,358.3,6875,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6875,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,6875,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,6875,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,6876,0)
 ;;=V10.61^^59^431^26
 ;;^UTILITY(U,$J,358.3,6876,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6876,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,6876,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,6876,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,6877,0)
 ;;=V12.03^^59^431^27
 ;;^UTILITY(U,$J,358.3,6877,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6877,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,6877,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,6877,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,6878,0)
 ;;=V10.82^^59^431^28
 ;;^UTILITY(U,$J,358.3,6878,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6878,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,6878,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,6878,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,6879,0)
 ;;=V10.62^^59^431^30
 ;;^UTILITY(U,$J,358.3,6879,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6879,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,6879,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,6879,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,6880,0)
 ;;=V10.63^^59^431^29
 ;;^UTILITY(U,$J,358.3,6880,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6880,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,6880,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,6880,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,6881,0)
 ;;=V11.2^^59^431^24
 ;;^UTILITY(U,$J,358.3,6881,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6881,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,6881,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,6881,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,6882,0)
 ;;=V15.81^^59^431^40
 ;;^UTILITY(U,$J,358.3,6882,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6882,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,6882,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,6882,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,6883,0)
 ;;=V10.43^^59^431^31
 ;;^UTILITY(U,$J,358.3,6883,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6883,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,6883,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,6883,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,6884,0)
 ;;=V12.71^^59^431^32
 ;;^UTILITY(U,$J,358.3,6884,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6884,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,6884,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,6884,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,6885,0)
 ;;=V10.46^^59^431^33
 ;;^UTILITY(U,$J,358.3,6885,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6885,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,6885,1,5,0)
 ;;=5^Hx of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,6885,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,6886,0)
 ;;=V11.0^^59^431^34
